Aqemia is a France-based AI platform that offers drug discovery solutions for the pharmaceutical sector.
Aqemia is a France-based AI platform that offers drug discovery solutions for the pharmaceutical sector.
Founded: 2019
Headquarters: Paris, France
Tech: Quantum-inspired physics algorithms + generative AI (QEMI platform)
Therapeutic focus: Oncology and immuno-oncology
Employee count (reported): 71
Total disclosed funding: >$100M (reported ~$132.75M)
Drug discovery for oncology and immuno-oncology
2019
Research Services
€30,000,000
Reported Series A extension; sources report Series A reached ~€60M by January 2024 when combined with earlier amounts.
$38,000,000
Reported round announced December 10, 2024 bringing cumulative disclosed funding past $100M.
€7,400,000
Reported public grant/program investment listed under France 2030.
“Includes institutional and public backers such as Bpifrance, Eurazeo, Elaia, Wendel Growth and France 2030”
| Company |
|---|
 |
 |
 |
 |
 |